This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Capurro, N. L. Articles by Epstein, S. E. Search for Related Content PubMed PubMed Citation Articles by Capurro, N. L. Articles by Epstein, S. E.

Circulation, Vol 59, 744-747, Copyright © 1979 by American Heart Association

ARTICLES

Aspirin-induced increase in collateral flow after acute coronary occlusion in dogs

NL Capurro, KC Marr, R Aamodt, RE Goldstein and SE Epstein

Aspirin (acetylsalicylic acid) has inhibitory effects on platelet function and prostaglandin synthesis. Since alterations in either platelet function or prostaglandin-mediated vascular responses could influence blood flow to ischemic myocardium, we tested the effects of aspirin on coronary collateral flow after acute occlusion of the left anterior descending coronary artery in dogs. Aspirin dose (600 mg i.v.) consistently inhibited in vitro ADP-induced platelet aggregation. In 13 open-chest dogs, regional myocardial blood flows (radioactive microsphere technique) were determined at 5 minutes and 4 hours after occlusion). In seven of these dogs, aspirin (600 mg i.v.) was administered 1 hour before occlusion. In the aspirin-treated dogs, collateral flow increased significantly (p less than 0.05), from 0.09 +/- 0.02 ml/min/g at 5 minutes to 0.15 and 0.02 ml/min/g 4 hours after occlusion. Collateral flow was not significantly altered over 4 hours in control dogs. The aspirin-induced increase in collateral flow was confined to epicardium (12 +/- 4% of normal zone flow at 5 minutes to 23 +/- 4% at 4 hours after occlusion).

This article has been cited by other articles:

				O. Ozdemir, M. Soylu, A. D. Demir, O. Alyan, S. Topaloglu, B. Geyik, and E. Kutuk Collaterals That Regressed After Angioplasty Can be Recruited to Protect the Left Ventricle in Case of an Acute Occlusion Angiology, September 1, 2005; 56(5): 517 - 523. [Abstract] [PDF]

				J. Mehta Platelets and Prostaglandins in Coronary Artery Disease: Rationale for Use of Platelet-Suppressive Drugs JAMA, May 27, 1983; 249(20): 2818 - 2823. [Abstract] [PDF]